Drug Pricing and Cost Work

Drug pricing is a key issue in the United States, and CP3 faculty regularly use their expertise to contribute to public discourse on many aspects of drug pricing and health care costs.

Selected News Interviews
Many Steps Needed Before Senate Bill Reduces Insulin Cost, Says Luo
Luo Explains Insulin Cost Changes on NPR
Luo Explains High Insulin Prices
Luo Comments on Tradeoffs to Pay for Insulin
WPXI Interviews Hernandez about Rising Prices for MS Drugs
Drug Pricing Is a "Huge Debate," Gellad tells PG
Marketplace Interviews Gellad About Drug Pricing

Recently Published Viewpoints
Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act
Walid F. Gellad, MD, MPH; Inmaculada Hernandez, PharmD, PhD
JAMA, October 18, 2022

Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes
Jing Luo
The Conversation, May 9, 2022

Decomposition of Expenditures for Insulins Across the Distribution Chain—Insights Into Rising Prices?
Chester B. Good, MD, MPH; Inmaculada Hernandez, PharmD, PhD
JAMA Health Forum, November 5, 2021

Recently Published Research
Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018
Olivier J. Wouters, PhD; Lucas A. Berenbrok, PharmD, MS; Meiqi He, MS; Yihan Li, BS; Inmaculada Hernandez, PharmD, PhD
JAMA Network Open, September 26, 2022

Trends in Out-of-Pocket Cost of Glucagon, 2010-2020
Margaret Zupa, MD; Robert Feldman, MS; Jing Luo, MD
JAMA Network Open, August 30, 2022

Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits
Rachel E. Sachs; Shelley A. Jazowski; Kyle A. Gavulic; Julie M. Donohue; Stacie B. Dusetzina
Journal of Health Politics, Policy, and Law, July 14, 2022

Doctor's Orders: An Rx to Curb Rising Drug Costs
Alexander Reardon, MD, Utibe Essien, MD, MPH, Jing Luo, MD, MPH, and Quentin R. Youmans, MD, MSc
MedPage Today, June 14, 2022

National trends in prescription drug expenditures and projections for 2022
Eric M Tichy, PharmD, MBA, BCPS, FCCP, FAST, James M Hoffman, PharmD, MS, Katie J Suda, PharmD, MS, Matthew H Rim, PharmD, MS, Mina Tadrous, PharmD, MS, PhD, Sandra Cuellar, PharmD, BCOP, John S Clark, PharmD, MS, BCPS, FASHP, Jennifer Ward, MBA, Glen T Schumock, PharmD, MBA, PhD, FCCP
American Journal of Health-System Pharmacy, April 6, 2022

All published work in drug pricing and cost